• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症:让-马丁·沙尔科的早期贡献

Amyotrophic lateral sclerosis: early contributions of Jean-Martin Charcot.

作者信息

Goetz C G

机构信息

Department of Neurological Sciences, Rush University/Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois 60612, USA.

出版信息

Muscle Nerve. 2000 Mar;23(3):336-43. doi: 10.1002/(sici)1097-4598(200003)23:3<336::aid-mus4>3.0.co;2-l.

DOI:10.1002/(sici)1097-4598(200003)23:3<336::aid-mus4>3.0.co;2-l
PMID:10679709
Abstract

Amyotrophic lateral sclerosis is historically an important entity because its manifestations involve distinct signs that can be correlated with gray and white matter lesions at specific sites within the central nervous system. Working at the end of the nineteenth century, the celebrated neurologist, Jean-Martin Charcot, used this disorder as a prototypic example of the power of his research method, termed "méthode anatomoclinique." Using clinical cases and autopsy material, he showed how anatomical lesions in the nervous system could be accurately determined by the presence of carefully analyzed clinical signs. Charcot's work on amyotrophic lateral sclerosis brought together neurological entities formerly considered as disparate disorders, primary amyotrophy and primary lateral sclerosis. In addition, these studies contributed to the understanding of spinal cord and brain stem anatomy and the organization of the normal nervous system. Because of Charcot's fundamental contributions, the eponym "Charcot's disease" has been used internationally in association with amyotrophic lateral sclerosis.

摘要

从历史角度来看,肌萎缩侧索硬化症是一个重要的病症,因为其临床表现涉及一些独特的体征,这些体征可与中枢神经系统特定部位的灰质和白质病变相关联。19世纪末,著名神经学家让 - 马丁·夏科运用这种病症作为他所谓“解剖临床法”研究方法强大之处的典型例子。通过临床病例和尸检材料,他展示了如何通过仔细分析临床体征的存在来准确确定神经系统中的解剖病变。夏科关于肌萎缩侧索硬化症的研究将以前被视为不同病症的原发性肌萎缩和原发性侧索硬化这两种神经病症归为一类。此外,这些研究有助于人们对脊髓和脑干解剖结构以及正常神经系统组织的理解。由于夏科的基础性贡献,“夏科病”这一名称在国际上一直与肌萎缩侧索硬化症相关联使用。

相似文献

1
Amyotrophic lateral sclerosis: early contributions of Jean-Martin Charcot.肌萎缩侧索硬化症:让-马丁·沙尔科的早期贡献
Muscle Nerve. 2000 Mar;23(3):336-43. doi: 10.1002/(sici)1097-4598(200003)23:3<336::aid-mus4>3.0.co;2-l.
2
Chapter 15: Jean-Martin Charcot and the anatomo-clinical method of neurology.第15章:让-马丁·沙可与神经病学的解剖临床方法
Handb Clin Neurol. 2010;95:203-12. doi: 10.1016/S0072-9752(08)02115-5.
3
[Jean-Martin Charcot, discovery and nomenclature of amyotrophic lateral sclerosis].[让-马丁·沙尔科,肌萎缩侧索硬化症的发现与命名]
Zhonghua Yi Shi Za Zhi. 2019 Jan 28;49(1):14-18. doi: 10.3760/cma.j.issn.0255-7053.2019.01.003.
4
Jean-Martin Charcot: Pioneer of Neurology.让-马丁·夏科:神经学先驱。
Cureus. 2024 Aug 13;16(8):e66762. doi: 10.7759/cureus.66762. eCollection 2024 Aug.
5
How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot.肌萎缩侧索硬化症名称的由来:让-马丁·沙尔科的临床病理学天赋
Arch Neurol. 2001 Mar;58(3):512-5. doi: 10.1001/archneur.58.3.512.
6
Amyotrophic Lateral Sclerosis: A Historical Perspective.肌萎缩侧索硬化症:历史视角
Neurol Clin. 2015 Nov;33(4):727-34. doi: 10.1016/j.ncl.2015.07.013.
7
[Jean-Martin Charcot in German neurology].[德国神经学中的让 - 马丁·沙可]
Nervenarzt. 2004 Feb;75(2):187-92. doi: 10.1007/s00115-003-1625-z.
8
The man behind the syndrome: Jean-Martin Charcot.该综合征背后的人物:让-马丁·沙可。
J Hist Neurosci. 1992 Jan;1(1):39-45. doi: 10.1080/09647049209525513.
9
"Stat Rosa Pristina Nomine, Nomina Nuda Tenemus": The Many Syndromes, Diseases, and Anatomic Structures Bearing Jean-Martin Charcot's Name.“白玫瑰以之名,我们拥有赤裸之名”:以让-马丁·夏科命名的多种综合征、疾病和解剖结构。
Eur Neurol. 2020;83(5):550-553. doi: 10.1159/000511028. Epub 2020 Oct 5.
10
[Figures in medical history. Jean-Martin Charcot].[医学史上的人物。让-马丁·沙可]
Praxis (Bern 1994). 2014 May 21;103(11):674. doi: 10.1024/1661-8157/a001663.

引用本文的文献

1
An Elongator mouse model of ALS spotlights TDP-43 in the motor neuron nucleolus.肌萎缩侧索硬化症的Elongator小鼠模型突显了运动神经元核仁中的TDP-43。
Commun Biol. 2025 Aug 21;8(1):1259. doi: 10.1038/s42003-025-08701-9.
2
Genetic epidemiology of amyotrophic lateral sclerosis in Cyprus: a population-based study.塞浦路斯肌萎缩侧索硬化症的遗传流行病学:一项基于人群的研究。
Sci Rep. 2024 Dec 28;14(1):30781. doi: 10.1038/s41598-024-80851-y.
3
Tofersen for SOD1 ALS.托法替布治疗 SOD1 型肌萎缩侧索硬化症。
Neurodegener Dis Manag. 2024;14(5):149-160. doi: 10.1080/17582024.2024.2402216. Epub 2024 Sep 27.
4
Jean-Martin Charcot: Pioneer of Neurology.让-马丁·夏科:神经学先驱。
Cureus. 2024 Aug 13;16(8):e66762. doi: 10.7759/cureus.66762. eCollection 2024 Aug.
5
History of ALS and the competing theories on pathogenesis: IFCN handbook chapter.肌萎缩侧索硬化症病史及发病机制的相关竞争理论:国际临床神经电生理联盟手册章节
Clin Neurophysiol Pract. 2023 Dec 12;9:1-12. doi: 10.1016/j.cnp.2023.11.004. eCollection 2024.
6
The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases.β-arrestins 的多效性功能及其在神经退行性疾病中的治疗潜力。
Exp Mol Med. 2024 Feb;56(1):129-141. doi: 10.1038/s12276-023-01144-4. Epub 2024 Jan 11.
7
Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms.调控肌萎缩侧索硬化症皮质兴奋性过高:聚焦于神经胶质机制。
Mol Neurodegener. 2023 Oct 19;18(1):75. doi: 10.1186/s13024-023-00665-w.
8
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives.间充质干细胞疗法治疗肌萎缩侧索硬化症(ALS)患者:疾病信息与未来展望的全面综述
Iran J Basic Med Sci. 2023;26(8):872-881. doi: 10.22038/IJBMS.2023.66364.14572.
9
Charcot identifies and illustrates amyotrophic lateral sclerosis.夏科氏(Charcot)识别并描述了肌萎缩侧索硬化症。
Free Neuropathol. 2021 May 18;2:12. doi: 10.17879/freeneuropathology-2021-3323. eCollection 2021 Jan.
10
Disturb mitochondrial associated proteostasis: Neurodegeneration and imperfect ageing.干扰线粒体相关的蛋白质稳态:神经退行性变与不完全衰老。
Front Cell Dev Biol. 2023 Mar 10;11:1146564. doi: 10.3389/fcell.2023.1146564. eCollection 2023.